NEW YORK (1010 WINS) — The Food and Drug Administration is set to approve third Pfizer and Moderna COVID-19 vaccine doses for immunocompromised people on Thursday, according to a new report.
Two sources familiar with the matter told NBC News the agency will amend the emergency use authorizations for both shots that day.
Listen to your favorite News/Talk station now on Audacy
Many immunocompromised people who have received the COVID-19 vaccine “are still vulnerable to [the virus] following vaccination because they may not mount an effective immune response to the shots,” the outlet reported.
Approximately 2.7% of adults in the United States have compromised immune systems, according to the outlet.
Related
